These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P, Tennstedt D. Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919 [Abstract] [Full Text] [Related]
5. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. Boggs PB, Ellis CN, Grossman J, Washburne WF, Gupta AK, Ball R, Shulan D. Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555 [Abstract] [Full Text] [Related]
6. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria. Sussman G, Jancelewicz Z. Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191 [Abstract] [Full Text] [Related]
7. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial. Pons-Guiraud A, Nekam K, Lahovsky J, Costa A, Piacentini A. Eur J Dermatol; 2006 Oct; 16(6):649-54. PubMed ID: 17229605 [Abstract] [Full Text] [Related]
8. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria. Salo OP, Harvey SG, Calthrop JG, Gibson JR. J Int Med Res; 1989 Oct; 17 Suppl 2():18B-21B. PubMed ID: 2569996 [Abstract] [Full Text] [Related]
9. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A. Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787 [Abstract] [Full Text] [Related]
10. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group. Leynadier F, Duarte-Risselin C, Murrieta M. Eur J Dermatol; 2000 Mar; 10(3):205-11. PubMed ID: 10725819 [Abstract] [Full Text] [Related]
11. [Effectiveness of loratadine vs. placebo in the treatment of urticaria-angioedema syndrome in patients with food allergy]. Pacor ML, Biasi D, Girelli D, Cortina P, Corrocher R. Clin Ter; 1993 Jun; 142(6):529-32. PubMed ID: 8354046 [Abstract] [Full Text] [Related]
12. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Breneman DL. Ann Pharmacother; 1996 Oct; 30(10):1075-9. PubMed ID: 8893110 [Abstract] [Full Text] [Related]
14. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Ring J, Hein R, Gauger A, Bronsky E, Miller B. Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962 [Abstract] [Full Text] [Related]
15. Cetirizine in the treatment of chronic urticaria. Juhlin L. Clin Ther; 1991 Jan; 13(1):81-6. PubMed ID: 1827614 [Abstract] [Full Text] [Related]
16. Combined H1 and H2 antihistamine therapy in chronic urticaria. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712 [Abstract] [Full Text] [Related]
17. [Results of treatment with loratadine in patients with chronic urticaria]. Siergiejko Z, Chyrek-Borowska S. Pol Tyg Lek; 1981 Jul; 49(14-15):334-6. PubMed ID: 7854994 [Abstract] [Full Text] [Related]
18. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Ortonne JP, Grob JJ, Auquier P, Dreyfus I. Am J Clin Dermatol; 2007 Jul; 8(1):37-42. PubMed ID: 17298105 [Abstract] [Full Text] [Related]
19. Comparison of the efficacy of four antihistamines in chronic urticaria. Youngchaiyud U. J Med Assoc Thai; 1988 Oct; 71(10):548-52. PubMed ID: 2907911 [No Abstract] [Full Text] [Related]